Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions

Helena Kratochvilova,1–3 Zdenka Lacinova,1–3 Jana Klouckova,1–3 Petra Kavalkova,2,3 Anna Cinkajzlova,1–3 Pavel Trachta,4 Jarmila Krizova,4 Marek Benes,5 Karin Dolezalova,6 Martin Fried,6 Zuzana Vlasakova,7 Terezie Pelikanova,7 Julius Spicak,5 Milos Mraz,2,3,7...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kratochvilova H, Lacinova Z, Klouckova J, Kavalkova P, Cinkajzlova A, Trachta P, Krizova J, Benes M, Dolezalova K, Fried M, Vlasakova Z, Pelikanova T, Spicak J, Mraz M, Haluzik M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/d5cbe7781cb642968b05b13ea8eaad62
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d5cbe7781cb642968b05b13ea8eaad62
record_format dspace
spelling oai:doaj.org-article:d5cbe7781cb642968b05b13ea8eaad622021-12-02T05:41:27ZNeudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions1178-7007https://doaj.org/article/d5cbe7781cb642968b05b13ea8eaad622019-03-01T00:00:00Zhttps://www.dovepress.com/neudesin-in-obesity-and-type-2-diabetes-mellitus-the-effect-of-acute-f-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Helena Kratochvilova,1–3 Zdenka Lacinova,1–3 Jana Klouckova,1–3 Petra Kavalkova,2,3 Anna Cinkajzlova,1–3 Pavel Trachta,4 Jarmila Krizova,4 Marek Benes,5 Karin Dolezalova,6 Martin Fried,6 Zuzana Vlasakova,7 Terezie Pelikanova,7 Julius Spicak,5 Milos Mraz,2,3,7 Martin Haluzik1–3,7 1Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 2Department of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, Prague, Czech Republic; 3Department of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, Prague, Czech Republic; 4Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; 5Hepatogastroenterology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 6Department of Surgery, OB Clinic, Prague, Czech Republic; 7Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Context: Neudesin has recently been identified as a novel regulator of energy expenditure in experimental animals; however, its role in humans remains unexplored.Objective: The aim of this study was to assess the effects of obesity and type 2 diabetes mellitus (T2DM) along with selected weight reducing interventions on serum neudesin levels and adipose tissue mRNA expression.Patients and methods: Fifteen obese subjects with T2DM undergoing endoscopic duodenal-jejunal bypass liner (DJBL) implantation, 17 obese subjects (11 with T2DM, 6 without T2DM) scheduled for gastric plication (GP), 15 subjects with functional hypoglycemia subjected to 72-hour acute fasting (AF), and 12 healthy controls were included in the study.Results: Baseline neudesin levels were comparable between all groups. DJBL increased neudesin at 6 and 10 months after the procedure (1.77±0.86 vs 2.28±1.27 vs 2.13±1.02 ng/mL, P=0.001 for baseline vs 6 vs 10 months) along with reduction in body weight and improvement of HbA1c without any effect on neudesin mRNA expression in subcutaneous adipose tissue. Conversely, GP did not affect neudesin levels despite marked reduction in body weight and improvement of HbA1c. In contrast, AF decreased neudesin levels during the entire period (1.74±0.54 vs 1.46±0.48 ng/mL, P=0.001 for baseline vs 72 hours) with no impact of subsequent re-alimentation on neudesin concentrations.Conclusion: Neudesin levels are differentially regulated during AF and chronic weight reduction induced by DJBL or GP. Further studies are needed to assess its possible significance in energy homeostasis regulation in humans. Keywords: neudesin, obesity, type 2 diabetes mellitus, bariatric surgery, acute fasting, weight reduction, energy homeostasisKratochvilova HLacinova ZKlouckova JKavalkova PCinkajzlova ATrachta PKrizova JBenes MDolezalova KFried MVlasakova ZPelikanova TSpicak JMraz MHaluzik MDove Medical PressarticleNeudesinobesitytype 2 diabetes mellitusbariatric surgeryacute fastingmetabolismSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 423-430 (2019)
institution DOAJ
collection DOAJ
language EN
topic Neudesin
obesity
type 2 diabetes mellitus
bariatric surgery
acute fasting
metabolism
Specialties of internal medicine
RC581-951
spellingShingle Neudesin
obesity
type 2 diabetes mellitus
bariatric surgery
acute fasting
metabolism
Specialties of internal medicine
RC581-951
Kratochvilova H
Lacinova Z
Klouckova J
Kavalkova P
Cinkajzlova A
Trachta P
Krizova J
Benes M
Dolezalova K
Fried M
Vlasakova Z
Pelikanova T
Spicak J
Mraz M
Haluzik M
Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
description Helena Kratochvilova,1–3 Zdenka Lacinova,1–3 Jana Klouckova,1–3 Petra Kavalkova,2,3 Anna Cinkajzlova,1–3 Pavel Trachta,4 Jarmila Krizova,4 Marek Benes,5 Karin Dolezalova,6 Martin Fried,6 Zuzana Vlasakova,7 Terezie Pelikanova,7 Julius Spicak,5 Milos Mraz,2,3,7 Martin Haluzik1–3,7 1Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 2Department of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, Prague, Czech Republic; 3Department of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, Prague, Czech Republic; 4Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; 5Hepatogastroenterology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 6Department of Surgery, OB Clinic, Prague, Czech Republic; 7Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Context: Neudesin has recently been identified as a novel regulator of energy expenditure in experimental animals; however, its role in humans remains unexplored.Objective: The aim of this study was to assess the effects of obesity and type 2 diabetes mellitus (T2DM) along with selected weight reducing interventions on serum neudesin levels and adipose tissue mRNA expression.Patients and methods: Fifteen obese subjects with T2DM undergoing endoscopic duodenal-jejunal bypass liner (DJBL) implantation, 17 obese subjects (11 with T2DM, 6 without T2DM) scheduled for gastric plication (GP), 15 subjects with functional hypoglycemia subjected to 72-hour acute fasting (AF), and 12 healthy controls were included in the study.Results: Baseline neudesin levels were comparable between all groups. DJBL increased neudesin at 6 and 10 months after the procedure (1.77±0.86 vs 2.28±1.27 vs 2.13±1.02 ng/mL, P=0.001 for baseline vs 6 vs 10 months) along with reduction in body weight and improvement of HbA1c without any effect on neudesin mRNA expression in subcutaneous adipose tissue. Conversely, GP did not affect neudesin levels despite marked reduction in body weight and improvement of HbA1c. In contrast, AF decreased neudesin levels during the entire period (1.74±0.54 vs 1.46±0.48 ng/mL, P=0.001 for baseline vs 72 hours) with no impact of subsequent re-alimentation on neudesin concentrations.Conclusion: Neudesin levels are differentially regulated during AF and chronic weight reduction induced by DJBL or GP. Further studies are needed to assess its possible significance in energy homeostasis regulation in humans. Keywords: neudesin, obesity, type 2 diabetes mellitus, bariatric surgery, acute fasting, weight reduction, energy homeostasis
format article
author Kratochvilova H
Lacinova Z
Klouckova J
Kavalkova P
Cinkajzlova A
Trachta P
Krizova J
Benes M
Dolezalova K
Fried M
Vlasakova Z
Pelikanova T
Spicak J
Mraz M
Haluzik M
author_facet Kratochvilova H
Lacinova Z
Klouckova J
Kavalkova P
Cinkajzlova A
Trachta P
Krizova J
Benes M
Dolezalova K
Fried M
Vlasakova Z
Pelikanova T
Spicak J
Mraz M
Haluzik M
author_sort Kratochvilova H
title Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
title_short Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
title_full Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
title_fullStr Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
title_full_unstemmed Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
title_sort neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/d5cbe7781cb642968b05b13ea8eaad62
work_keys_str_mv AT kratochvilovah neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT lacinovaz neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT klouckovaj neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT kavalkovap neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT cinkajzlovaa neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT trachtap neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT krizovaj neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT benesm neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT dolezalovak neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT friedm neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT vlasakovaz neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT pelikanovat neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT spicakj neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT mrazm neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
AT haluzikm neudesininobesityandtype2diabetesmellitustheeffectofacutefastingandweightreducinginterventions
_version_ 1718400261116919808